Chinese PD-SNCA Registry

计划入组 3,000 人 · 首次发布于 2018 年 5 月 14 日

Molecular and Functional Imaging in SNCA, Parkin and PINK1

首次发布于 2019 年 9 月 10 日

First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)

计划入组 46 人 · 首次发布于 2025 年 10 月 14 日

SNCA-21

ARO-SNCA

SNCA ASO(BMS)

URI - Soca

Slovenia

seca GmbH & Co. KG

Germany

Galderma Research & Development SNC

France

Arrowhead Pharmaceuticals Secures $200 Million Novartis Deal for Alpha-Synuclein siRNA Therapy

Shape Therapeutics Secures MJFF Grant to Advance SHP-201, a One-Time RNA-Editing Gene Therapy for Parkinson's Disease

RNA Interference Therapy Market Expands with 90+ Drugs in Development Across 40+ Companies